Cosmos Health Inc COSM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if COSM is a good fit for your portfolio.
News
-
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
-
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
-
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
-
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
-
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
-
Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price
-
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
-
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
Trading Information
- Previous Close Price
- $0.75
- Day Range
- $0.71–0.78
- 52-Week Range
- $0.47–4.00
- Bid/Ask
- $0.72 / $0.76
- Market Cap
- $12.38 Mil
- Volume/Avg
- 57,009 / 209,391
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.14
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 102
- Website
- https://www.cosmoshold.com
Valuation
|
Metric
|
COSM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.21 |
Price/Sales | 0.14 |
Price/Cash Flow | — |
Price/Earnings
COSM
Financial Strength
|
Metric
|
COSM
|
|---|---|
Quick Ratio | 1.41 |
Current Ratio | 2.06 |
Interest Coverage | −6.96 |
Quick Ratio
COSM
Profitability
|
Metric
|
COSM
|
|---|---|
Return on Assets (Normalized) | −6.48% |
Return on Equity (Normalized) | −11.95% |
Return on Invested Capital (Normalized) | −6.33% |
Return on Assets
COSM
Medical Distribution Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MCK
| McKesson Corp | Jqbjdfzm | Ccyjsvf | $71.7 Bil | |
COR
| Cencora Inc | Vdmcptcm | Chsscxz | $44.2 Bil | |
CAH
| Cardinal Health Inc | Qdvrfwrw | Rqwzkv | $23.7 Bil | |
SHTDF
| Sinopharm Group Co Ltd | — | Bbynyhf | $9.0 Bil | |
SHTDY
| Sinopharm Group Co Ltd ADR | — | Csshyjh | $9.0 Bil | |
SHPMF
| Shanghai Pharmaceuticals Holding Co Ltd Class H | — | Wzzmxkp | $8.6 Bil | |
SHPMY
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H | — | Swmcv | $8.6 Bil | |
AMFPF
| Amplifon SpA Az nom Post Frazionamento | — | Blqrjjx | $8.1 Bil | |
MEPDF
| Medipal Holdings Corp | — | Ggmd | $3.3 Bil | |
MAHLY
| Medipal Holdings Corp ADR | — | Gwqv | $3.0 Bil |